Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
In Sub-Saharan Africa, chronic haemodialysis (HD) dialysis remains the primary modality of kidney replacement therapy; however, it places a significant burden on both patients and the health care systems. Despite the limited data on patients' dialysis-related expenses, high out of pocket and indirect costs pose a significant barrier to accessibility and utilisation of HD in resource limited countries.
This was a descriptive cross sectional study involving all adult incident and prevalent chronic HD patients in Zambia that were aged 18 years and above. Patients were recruited from 13 public and private HD facilities across the country. The study was conducted from April 1,2023- August 30, 2025. The Tropical Diseases Research Centre (TRDC) approved the study. The patients’ social demographic, clinical parameters, insurance cover, out of patients costs, indirect and HD dialysis related characteristics were analysed
A total of 313 patients were enrolled in the study with 39.9% being male. The mean age was 46. 2 years (range 19-91 years). The median duration on maintenance HD was 2.0 years (IQR: 2-3) years. Nearly 80% attained a second level education; 66.7% were married and 41.5% unemployed. Notably, 37% reported unemployment as a direct consequence of kidney failure. Nearly all participants (99.6%) were covered for chronic dialysis under the national health insurance scheme (NHIMA); with 48.2% from the private sector. NHIMA covered medications in 81.5%. The reported median monthly income was USD250 (IQR:125-375) with a patients’ monthly median out of pocket expense for NHIMA USD2.5 (IQR 1.9-2.5), transport USD 55.3(IQR: 2.8-100), feeding USD 25 (IQR: 16.7-50) with median distance to dialysis unit 10km (IQR:5-20). NHIMA covered the costs for the following: HD consumables per session at USD 110 (IQR 95–115); medications including erythropoietin, iron sucrose, heparin, and vitamin D at USD 45 (IQR 25–58); and monthly laboratory tests at USD 136 (IQR 93–187). Majority (90.1%) were accessing maintenance HD three times weekly.
Despite comprehensive coverage of maintenance haemodialysis patients under the national health scheme, this study highlights substantial monthly indirect costs and out-of-pocket expenditures that pose barriers to optimal service delivery.
